Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:TCBP

TC Biopharm (TCBP) Stock Price, News & Analysis

TC Biopharm logo

About TC Biopharm Stock (NASDAQ:TCBP)

Key Stats

Today's Range
$0.50
$1.54
50-Day Range
$0.68
$0.68
52-Week Range
$0.50
$160.00
Volume
5.33 million shs
Average Volume
177,918 shs
Market Capitalization
$279.21 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$48.00
Consensus Rating
Buy

Company Overview

Receive TCBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TC Biopharm and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TCBP Stock News Headlines

GOLD ALERT
Gold has shattered records, soaring past $3,800 an ounce... But Stansberry Senior Partner Dr. David "Doc" Eifrig says history shows it could be on the verge of its biggest bull run in over half a century.tc pixel
TC BioPharm Holdings PLC (TCBPY)
TC Biopharm announces transition to OTC Markets from Nasdaq
See More Headlines

TCBP Stock Analysis - Frequently Asked Questions

TC Biopharm shares reverse split on the morning of Monday, February 10th 2025.The 1-20 reverse split was announced on Wednesday, February 5th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Friday, February 7th 2025. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

TC Biopharm (TCBP) raised $17 million in an initial public offering (IPO) on Friday, February 11th 2022. The company issued 4,100,000 shares at $4.25 per share. EF Hutton served as the underwriter for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that TC Biopharm investors own include Johnson & Johnson (JNJ), Procter & Gamble (PG), Taiwan Semiconductor Manufacturing (TSM), Exxon Mobil (XOM), International Business Machines (IBM), NextEra Energy (NEE) and Union Pacific (UNP).

Company Calendar

Today
10/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TCBP
CIK
1872812
Fax
N/A
Employees
80
Year Founded
2013

Price Target and Rating

High Price Target
$48.00
Low Price Target
$48.00
Potential Upside/Downside
+6,948.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.67
Current Ratio
1.12
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$4.76 million
Price / Sales
0.06
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$519.58 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
410,000
Free Float
28,000
Market Cap
$279.21 thousand
Optionable
Not Optionable
Beta
0.01

Social Links

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:TCBP) was last updated on 10/6/2025 by MarketBeat.com Staff
From Our Partners